Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)

Clinical trial NCT01188811 · COMPLETED

Trial details

NCT number: NCT01188811
Sponsor: VA Office of Research and Development
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Chronic Progressive

Start date: 2010-10-01
Primary completion: 2015-08-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.